Coagulation Factor VIIa variant
MAA-202
Phase 2 mab terminated
Quick answer
Coagulation Factor VIIa variant for Factor VII Deficiency is a Phase 2 program (mab) at CATALYST PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- CATALYST PHARMACEUTICALS, INC.
- Indication
- Factor VII Deficiency
- Phase
- Phase 2
- Modality
- mab
- Status
- terminated